Drugs / Methyprednisolone
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 21 trial | ||||||
| Phase 2 | NCT00292760 | — | chronic lymphocytic leukemia/small lymphocytic lymphoma | Royal Marsden NHS Foundation Trust | Completed | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT02981212 Background | Jun 2016 → Aug 2018 | IgA glomerulonephritis | Yonsei University | Unknown | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | methyprednisolone | “methyprednisolone” NCT02981212 ↗ |